Why Veteran Researcher Ed Yardeni Is Now Backing the "Impressive 493" Over Big Tech

Ed Yardeni, a long-time tech bull and president of Yardeni Research, has moved to underweight the “Magnificent Seven” and instead favors the other 493 S&P 500 companies, arguing the current concentration—about 45% of the index’s market cap—looks unsustainably high. He believes AI-driven productivity gains will be broadly adopted by non-tech sectors, calling out financials, industrials and healthcare as likely beneficiaries that can use AI to boost efficiency rather than having to build AI products themselves. While the Magnificent Seven have earned premium multiples (Roundhill’s MAGS is up roughly 21% YTD and Tesla trades near a 300x P/E), Yardeni sees them as only “somewhat” overvalued and expects eventual mean reversion, suggesting portfolio rotations into the broader market could capture dispersed AI upside.

Analysis

Ed Yardeni of Yardeni Research, a 15-year tech bull, has moved to underweight the "Magnificent Seven" and is advocating ownership of the remaining 493 S&P 500 stocks he calls the "Impressive 493." He highlights that the Magnificent Seven now account for about 45% of the S&P 500's market capitalization and describes the group as "somewhat" overvalued; Roundhill's MAGS ETF is up roughly 21% year-to-date while Tesla trades near a 300x P/E.

Yardeni's shift rests on concentration risk and the expectation that AI-driven productivity gains will diffuse across non-tech sectors rather than remain concentrated among AI product creators. He specifically cites financials, industrials and healthcare as beneficiaries that can use AI to boost efficiency, giving the example of technology easing medical-record sharing.

For investors this implies a potential rotation opportunity as market-cap concentration reverts toward historical norms, but not a repudiation of tech — both cohorts can still outperform if fundamentals justify premiums. Key risks are continued concentration and the possibility that premium valuations remain warranted by earnings; monitor valuation dispersion, fund flows into mega-cap ETFs, sector earnings revisions and AI adoption metrics for evidence of durable breadth improvement.

Key Decisions for Investors

• Reassess position sizing in mega-cap tech and consider trimming concentrated holdings in the Magnificent Seven given the 45% S&P concentration and "somewhat" overvaluation, especially where exposure to Tesla's elevated 300x P/E is sizable
• Rotate selectively into financials, industrials and healthcare companies with demonstrable AI adoption and clear near-term productivity or earnings leverage rather than broad thematic bets
• Favor bottom-up stock selection and valuation discipline when increasing exposure to the "Impressive 493" and monitor fund flows into MAGS and mega-cap ETFs as a concentration-risk indicator
• Use hedges or reduce position sizes if breadth does not improve through upcoming earnings cycles and track adoption metrics, sector earnings revisions and concentration indicators to guide rebalancing